Friedel, Evelyn B. N.
Tebartz van Elst, Ludger
Beringer, Malina
Endres, Dominique
Runge, Kimon
Maier, Simon
Kornmeier, Jürgen
Bach, Michael
Domschke, Katharina
Heinrich, Sven P.
Nickel, Kathrin http://orcid.org/0000-0001-9863-317X
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (462923710, 462923710)
Universitätsklinikum Freiburg
Article History
Received: 15 March 2024
Accepted: 10 May 2024
First Online: 28 May 2024
Declarations
:
: EF, MBe, DE, KR, SM, JK, MBa, SH, KN: no conflict of interest. LTvE: Advisory boards,lectures, or travel grants within the last 3 years: Roche, Eli Lilly, Janssen-Cilag,Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics; KD: Steering Committee Neurosciences, Janssen.
: The Ethics Committee of the University of Freiburg (Approval ID: 314/18) approved the study. All participants gave written informed consent to participate.